相关实验视频
Updated: Jul 11, 2025

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
Published on: April 30, 2020
对评估肺结核治疗有效性的生物标志物的新见解:叙述性审查
Fuzhen Zhang1,2, Fan Zhang2, Yu Dong1
1Department of Bacteriology and Immunology, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis & Thoracic Tumor Research Institute, No. 97, Machang, Tongzhou District, Beijing, 101149, People's Republic of China.
评估结核病 (TB) 治疗的有效性需要比目前的唾液测试更好的方法. 新的生物标志物显示出监测耐药结核病 (DR-TB) 治疗的前景,但需要进一步研究临床使用.
科学领域:
- 生物医学研究的研究.
- 传染病 传染病 传染病
- 临床诊断 临床诊断 临床诊断
背景情况:
- 目前世界卫生组织 (WHO) 推的评估肺结核 (PTB) 治疗疗效的方法,唾液涂抹和培养,具有显著的局限性.
- 这些局限性包括敏感性低,培养时间长,易受污染,需要改进诊断方法.
- 迫切需要可靠的生物标志物来准确评估PTB治疗反应,特别是耐药结核病 (DR-TB).
研究的目的:
- 系统地审查和更新用于评估PTB治疗疗效的生物标志物的最新进展.
- 确定监测Mycobacterium结核病 (MTB) 治疗的现有和新兴生物标志物的局限性.
- 为新的生物标志物发现和评估模型提供科学基础,作为标准方法的替代方案.
主要方法:
- 对用于评估PTB治疗疗效的生物标志物的最近研究进行系统审查.
- 对Mycobacterium tuberculosis (MTB) 特定的生物标志物和宿主衍生的生物标志物的分析.
- 评估与每个生物标志物类型相关的进步和局限性.
主要成果:
- 许多针对MTB和宿主反应的新型生物标志物已被研究用于PTB治疗监测.
- 虽然一些生物标志物显示出潜力,但它们往往有局限性,阻碍了它们广泛的临床应用.
- 与单个标志物相比,生物标志物的组合可能提供一种更强大的方法来评估治疗疗效.
结论:
- 现有的基于唾液的方法来评估结核病治疗的有效性是不理想的.
- 新兴生物标志物提供了潜在的替代品,但需要进一步验证和优化.
- 未来的研究应该专注于开发和验证可靠的生物标志物组合,以便在临床实践中有效监测PTB治疗.
更多相关视频
06:26Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
相关概念视频
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...